MSH6 and neoplasm: In one immunohistochemical analysis involving 28 cases in Iran, researchers examined PD-L1 expression both within tumor cells and the surrounding peritumoral inflammatory infiltrate, alongside MMR status determined through MSH6 and PMS2 markers.